Table 1.
Initial body weight, final body weight, body weight gain, liver index and spleen index in differente experimental groups
| Groups | Body weight (g) | Body weight gain (g) | Liver index (%) | Spleen index (%) | |
|---|---|---|---|---|---|
| Initial | Final | ||||
| Sham | 180.41 ± 14.31 | 321.50 ± 18.49 | 141.09 ± 12.72 | 2.75 ± 0.42 | 0.25 ± 0.035 |
| CCl4 | 179.66 ± 10.10 | 272.40 ± 21.03 | 92.74 ± 18.61* | 5.97 ± 0.49* | 0.50 ± 0.055* |
| CCl4 + EPP | 180.82 ± 9.28 | 308.22 ± 19.44 | 128.30 ± 24.50# | 3.58 ± 0.63# | 0.36 ± 0.055# |
| CCl4 + EPS | 184.00 ± 10.98 | 309.10 ± 20.72 | 125.10 ± 22.09# | 3.55 ± 0.55# | 0.35 ± 0.039# |
EPP (150 mg/kg) and EPS (100 mg/kg) were administered orally for 4 weeks. The values are expressed as the mean ± S.D. (n = 10).*P < 0.05, compared with the sham group, # P < 0.05, compared with the CCl4 group